nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Betamethasone—systemic lupus erythematosus	0.214	0.632	CbGbCtD
Nandrolone phenpropionate—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.138	0.208	CrCrCtD
Nandrolone phenpropionate—CYP19A1—Dexamethasone—systemic lupus erythematosus	0.124	0.368	CbGbCtD
Nandrolone phenpropionate—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.11	0.167	CrCrCtD
Nandrolone phenpropionate—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.093	0.141	CrCrCtD
Nandrolone phenpropionate—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.093	0.141	CrCrCtD
Nandrolone phenpropionate—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.0807	0.122	CrCrCtD
Nandrolone phenpropionate—Progesterone—Prednisolone—systemic lupus erythematosus	0.0782	0.118	CrCrCtD
Nandrolone phenpropionate—Testosterone—Prednisolone—systemic lupus erythematosus	0.0679	0.103	CrCrCtD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—HIP1—systemic lupus erythematosus	8.86e-05	0.115	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—XRCC6—systemic lupus erythematosus	3.46e-05	0.0448	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—RXRA—systemic lupus erythematosus	2.94e-05	0.038	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	2.46e-05	0.0319	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—RXRA—systemic lupus erythematosus	2.28e-05	0.0295	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	2.12e-05	0.0274	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—VDR—systemic lupus erythematosus	2.07e-05	0.0268	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—VDR—systemic lupus erythematosus	2.04e-05	0.0264	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—NR3C1—systemic lupus erythematosus	1.86e-05	0.0241	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	1.8e-05	0.0233	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	1.75e-05	0.0226	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	1.74e-05	0.0225	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	1.74e-05	0.0225	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	1.63e-05	0.0211	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	1.47e-05	0.019	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—systemic lupus erythematosus	1.44e-05	0.0187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	1.43e-05	0.0185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.36e-05	0.0176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	1.14e-05	0.0147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	1.13e-05	0.0146	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.1e-05	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	1.1e-05	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDKN1B—systemic lupus erythematosus	1.06e-05	0.0137	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NAT2—systemic lupus erythematosus	1.05e-05	0.0136	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.03e-05	0.0134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	1.02e-05	0.0131	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	9.63e-06	0.0125	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	9.55e-06	0.0124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	9.16e-06	0.0119	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	9.08e-06	0.0118	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	9.06e-06	0.0117	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	8.39e-06	0.0109	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	7.95e-06	0.0103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	7.88e-06	0.0102	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	7.59e-06	0.00982	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	7.23e-06	0.00935	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	7.16e-06	0.00926	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	6.5e-06	0.00841	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	6.36e-06	0.00824	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	6.27e-06	0.00812	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	6.01e-06	0.00778	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—RXRA—systemic lupus erythematosus	5.87e-06	0.0076	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	5.48e-06	0.0071	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	5.48e-06	0.00709	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	5.41e-06	0.007	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	5.2e-06	0.00673	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	5.15e-06	0.00667	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	5.15e-06	0.00666	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	5.14e-06	0.00665	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	5.02e-06	0.00649	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.95e-06	0.00641	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	4.77e-06	0.00618	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MTA2—systemic lupus erythematosus	4.66e-06	0.00603	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	3.56e-06	0.0046	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	3.15e-06	0.00407	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	3.13e-06	0.00405	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	3.12e-06	0.00403	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	3.12e-06	0.00403	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SNRPB—systemic lupus erythematosus	3.05e-06	0.00394	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	3.05e-06	0.00394	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.96e-06	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.95e-06	0.00382	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	2.89e-06	0.00373	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.82e-06	0.00365	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.72e-06	0.00352	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	2.69e-06	0.00348	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.59e-06	0.00335	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	2.55e-06	0.0033	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.54e-06	0.00329	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	2.47e-06	0.0032	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.45e-06	0.00318	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	2.45e-06	0.00317	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.25e-06	0.00292	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.25e-06	0.00292	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.1e-06	0.00272	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	2e-06	0.00258	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.97e-06	0.00255	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT2—systemic lupus erythematosus	1.79e-06	0.00232	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.71e-06	0.00222	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RXRA—systemic lupus erythematosus	1.5e-06	0.00194	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.42e-06	0.00184	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—VDR—systemic lupus erythematosus	1.36e-06	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.28e-06	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR3C1—systemic lupus erythematosus	1.22e-06	0.00158	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.12e-06	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RXRA—systemic lupus erythematosus	1e-06	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—systemic lupus erythematosus	9.47e-07	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.31e-07	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—systemic lupus erythematosus	6.34e-07	0.00082	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—systemic lupus erythematosus	5.7e-07	0.000738	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NOS3—systemic lupus erythematosus	5.45e-07	0.000705	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—systemic lupus erythematosus	4.99e-07	0.000645	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EP300—systemic lupus erythematosus	4.15e-07	0.000537	CbGpPWpGaD
